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Background/Aims: Krüppel-like factor 4 (KLF4) is an 
epithelial-speciﬁ  c transcription factor primarily expressed in 
the gastrointestinal tract that mediates growth arrest in the 
colonic epithelium. We tried to find whether KLF4 expres-
sion is associated with the progression and differentiation of 
colorectal cancer. Methods: We detected KLF4 expression 
in 109 colorectal specimens (40 normal appearing mucosa, 
7 adenomas, and 62 carcinomas) by immunohistochemistry 
using a tissue microarray. Western blot and RT-PCR analyses 
were also performed. Results: The upregulation of KLF4 
expression in carcinoma tissue was statistically significant 
(p<0.05) when compared to normal appearing mucosa. The 
negative and weak positive staining rates in normal appear-
ing mucosa, adenoma, and carcinoma were 42.5%, 71.4%, 
and 82.3%, respectively, indicating a decreased degree of 
KLF4 expression over the course of progressive transforma-
tion of normal cells into malignant derivatives. KLF4 protein 
levels showed no correlation with sex, age, or metastatic 
state (p>0.05), while KLF4 protein expression correlated with 
the diagnostic stage (p<0.05). Furthermore, strong KLF4 
staining was detected in 22.9% (11/48) and 0% (0/14) of 
well/moderately and poorly differentiated colorectal cancers, 
respectively. Our results clearly indicate that KLF4 protein 
expression signiﬁ  cantly correlates with the degree of differ-
entiation in colorectal cancers (p<0.05). KLF4 expression 
in RKO cells is also upregulated by butyrate, an inducer of 
differentiation. Conclusions: Downregulation of KLF4 ex-
pression may lead to more poorly differentiated tumors. (Gut 
Liver 2011;5:154-159)
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INTRODUCTION
Colon and rectum cancers (CRC) accounted for about 1.23 
million new cases in 2008 (9.7% of the world total). In terms of 
incidence, colorectal cancers rank third in frequency.
1 At present 
time, with the development of living conditions and changes 
of life behaviors, CRC has become more and more frequent in 
China. Several lines of evidence indicated that tumorigenesis 
is a multistep process and these steps reflect genetic alterations 
that drive the progressive transformation of normal human cells 
into highly malignant derivatives.
2 Investigators have made sig-
nificant progress in understanding the molecular mechanisms 
that lead to colorectal cancer. In recent days, more studies were 
focused on the role of transcription factor in regulating abnor-
mal cell growth.
Krüppel-like factor 4 (KLF4), first identified as a gut epithelial 
enriched gene,
3 is a member of the KLF family of conserved 
zinc-finger-containing eukaryotic transcription factors. It en-
codes a transcription factor with three C2H2 zinc fingers in 
the carboxyl terminus.
4 KLF4, formerly known as gut-enriched 
Krüppel-like factor (GKLF) or epithelial zinc finger (EZF), is ex-
pressed in the epithelia of skin, lung, gastrointestinal tract and 
several other organs. 
KLF4 is an important regulator of cell cycle in vitro. It con-
trols the G1/S cell cycle checkpoint, and is also required to 
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prevent the G2/M transition after DNA damage. KLF4 is associ-
ated with both active and repressive genes that are involved in 
cell-cycle regulation and differentiation.
5 Taken together, these 
studies point to a wide-ranging and crucial effect of KLF4 in 
maintaining the integrity of the cell cycle. The observation that 
KLF4 exerts an important checkpoint function suggested that 
KLF4 may have a tumor suppressor effect.
A survey of the tissue distribution in adult mice revealed that 
KLF4 was highly expressed in terminally differentiated, post-
mitotic epithelial cells of the intestinal tract.
3 Disorder of the 
expression of KLF4 has been associated with some kinds of car-
cinoma, for example, KLF4 was increased during the progres-
sion of breast cancer
6 and dysplastic oral squamous epithelium,
7 
while it was decreased in colorectal
8 and esophageal cancer,
9 
etc. 
Many researches are focused in colorectal cancer in vivo and 
in vitro. Some studies show the lower expression of KLF4 in 
colorectal cancer, but there is no any report on this gene ex-
pression in colorectal cancer in Chinese population. Here, we 
detected the expression of KLF4 in 109 colorectal specimens 
(40 normal appearing mucosa, 7 adenoma, and 62 carcinoma) 
to study the relationship between KLF4 expression and clinico-
pathological parameters, such as sex, age, TNM stage, metas-
tasis state and differentiation. We tried to find the evidence in 
vivo that if KLF4 is associated with the progression of colorectal 




Archived paraffin blocks of formalin-fixed surgical specimens 
corresponding to 109 cases of colorectal tissues, diagnosed 
between 2001 and 2003, were obtained from the first affiliated 
hospital of Anhui Medical University. Fresh colorectal tumor 
and adjacent normal-appearing colorectal mucosa were also 
obtained from the hospital. The specimens were neither treated 
by radiotherapy nor chemotherapy. Patient characteristics were 
summarized in Table 1 (The ages of the patients ranged from 17 
to 78 years).
2. Tissue microarray (TMA)
According to the H&E stain of pathological section, the tissue 
blocks were selected and be marked with the typical areas in the 
section by two pathologists. The TMAs were assembled using 
a tissue-arraying instrument, consisting of thin-walled stain-
less steel biopsy needles and stylets used to empty and transfer 
the needle content out of the paraffin block (recipient block). A 
large diameter stylet (1.5 mm) was used for sampling, and non-
necrotic areas of the blocks were routinely sampled with two 
replicated core samples of tumor and normal (if present) regions 
from each donor block. To combine donor cores with the recipi-
ent block, the paraffin wax was reheated for 1 hour at 55°C. 
Forty-two tissues were included in each tissue array block. Sec-
tions of 4 μm were cut from the resulting microarray one day 
before immunostaining.
3. Immunohistochemistry  
TMAs were deparaffinized, rehydrated and immersed in 3% 
hydrogen peroxide methanol solution for 10 minutes at room 
temperature. The sections was incubated with H-180 polyclonal 
rabbit antibody against human KLF4 (Santa Cruz Biotechology, 
Santa Cruz, CA, USA) at 4°C for 14 hours, and sequentially in-
cubated with biotinylated goat anti-rabbit IgG and streptavidin- 
horseradish peroxidase. Streptavidin-peroxidase method was 
routinely used.
4. Immunoscoring 
All slides were examined and scored independently by two 
pathologists. A positive reaction was indicated by a reddish-
brown precipitate in the cells. Depending on the percentage of 
positive cells and staining intensity, KLF4 staining was classified 
into three groups: negative, weak positive, and strong positive. 
Specifically, the percentage of positive cells was divided into 
five grades (percentage scores): <10% (0), 10–25% (1), 25–50% 
(2), 50–75% (3), and >75% (4). The intensity of staining was 
divided into four grades (intensity scores): no staining (0), light 
brown (1), brown (2), and dark brown (3). KLF4 staining positiv-












  Male 42 3 (7.1) 31 (73.8) 8 (19.0) 0.674
  Female 20 3 (15.0) 14 (7.0) 3 (15.0)
Age at diagnosis
  ≥54 32 3 (9.3) 23 (71.9) 6 (18.8) 1.000
  <54 30 3 (10.0) 22 (73.3) 5 (16.7)
Metastasis
  Yes 35 5 (14.3) 22 (62.9) 8 (22.9) 0.172
  No 27 1 (3.7) 23 (65.7) 3 (8.6)
TNM stage 
  I+II 34 5 (14.7) 20 (58.8) 9 (26.5) 0.030
  III+IV 28 1 (3.6) 25 (89.3) 2 (7.1)
Differentiation 
  Well and mod 48 2 (4.2) 35 (72.9) 11 (22.9) 0.007
  Poorly 14 4 (28.6) 10 (71.4) 0 (0)
Data are presented as number (%).
Fisher’s exact probabilistic method is done to determine the statistic 
significance of the relationship of KLF4 expression of various vari-
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ity was determined by the formula: overall scores=percentage 
score×intensity score. The overall score of ≤3 was defined as 




Statistical tests were performed using Stata 8.0 software (Stata 
Co., College Station, TX, USA). Proportions were compared by 
χ
2 test and Fisher’s exact test.
6. Cell culture 
Human colorectal cancer cell line RKO was cultured in DMEM 
medium (high glucose) supplemented with 10% (v/v) bovine 
serum. KLF4 expression level was detected in RKO cells treated 
with 0 to 3 mM butyrate for 4 hours. 
7. RT-PCR
RNA extractions and PCR were carried out with kit (TaKaRa 
RNA PCR Kit (AMV) ver.3.0; TaKaRa, Shiga, Japan), according 
to the manufacturer’s instructions. For detecting the expression 
of KLF4 mRNA, primers which amplify the coding sequence of 
KLF4 cDNA (+864 to +1298) were used. The forward primer was 
5`-CCACCGGCCGGCTGCACACGACT-3`, The reverse primer was 
5`-TCATCTGAGCGGGCGAATTTCCATCCACA-3`.
9 The positive 
control was β-actin, while the negative control was water. Each 
PCR reaction was hot started at 94°C for 5 minutes, and then 
amplified for 30 cycles (94°C for 30 seconds, 56°C for 40 sec-
onds, and 72°C for 30 seconds). PCR products were visualized 
on a 2% agarose gel stained by ethidium bromide.
8. Western blot analysis 
Protein samples were isolated from fresh specimens of can-
cerous or noncancerous portions. Standard western blot was 
performed with the H-180 polyclonal rabbit antibody against 








Normal mucosa 40 0 (0) 17 (42.5) 23 (57.5) <0.001*
Adenoma   7 0 (0)   5 (71.4)   2 (28.6) 0.228
̈
Carcinoma 62    6 (9.7) 45 (72.6) 11 (17.7) 0.809
̉
Data are presented as number (%).
Fisher’s exact test is done with the STATA software program to deter-
mine the statistical significance of the level of expression of KLF4 in 
different type tissue specimens.
*Normal mucosa versus carcinoma; 
̈Normal mucosa versus adeno-
ma; 
̉Adenoma versus carcinoma.
Fi g.  1. Immunostaining of human colorectal cancers with anti-KLF4 antibody (original magnification, ×200). Staining is indicated as a brown 
precipitate. Unstained nuclei appear blue from the hematoxylin counterstain. (A) Normal appearing colonic mucosa. KLF4 immunostains are 
predominantly cytoplasmic in the normal crypt epithelium and primarily distributed around the nucleus, a pattern clearly indicative of cell polar-
ity. (B) Colonic villous adenoma. KLF4 immunostains are cytoplasmic and nuclear in the crypt epithelium. Cell polarity is observed. (C) Tubular 
adenocarcinoma (well-differentiated). KLF4 staining is strong in the cytoplasm and clearly observed in the nuclei of some cells. (D) Papillary ad-
enocarcinoma (moderately differentiated). KLF4 immunostaining is diffusely distributed in the cytoplasm. Several nuclear yellow stains are also 
observed. (E) Mucous adenocarcinoma (poorly differentiated). KLF4 immunostaining is predominantly cytoplasmic and is weakly positive. Most 
cells demonstrates a loss of cell polarity. (F) Another specimen illustrates the difference in KLF4 protein between poorly and well-differentiated 
cells; the yellow stain is darker in the well-differentiated crypt (white arrow) than in the poorly differentiated portion (black arrow).Hu R, et al: KLF4 Expression Correlates with the Degree of Differentiation in Colorectal Cancer  157
human KLF4 (Santa Cruz Biotechnology).
RESULTS
1. KLF4 protein expression of colorectal normal mucosa, 
adenoma, and carcinoma
KLF4 protein expression was detected in 40 normal appearing 
mucosa, 7 adenoma, and 62 carcinoma (Table 2). The negative/
weak positive staining of KLF4 was 42.5% in normal mucosa, 
while the rate was up to 71.4% and 82.3% in adenoma, and 
carcinoma. A decreased tendency was evident, though not sig-
nificant, in KLF4 expression in the course of normal, adenoma, 
and carcinoma. Scoring carefully, the strong positive rate of 
normal appearing mucosa, adenoma, and carcinoma were 
57.5%, 28.6%, and 17.7%. The staining patterns were significant 
different between normal mucosa and carcinoma (p<0.01).  
2. Characteristics of the patients and the KLF4 protein ex-
pression
To investigate what properties of colorectal carcinoma are 
associated with KLF4 expression, we identified 109 surgical 
specimens which were well characterized for clinicopathologi-
cal parameters, including sex, age at diagnosis, metastasis state, 
TNM stage
11 and differentiation (Table 1). Obviously, the level 
of KLF4 had no correlation with the sex, age, and metastasis 
state (p>0.05). Meanwhile, strong KLF4 staining was detected 
higher in well and moderately differentiated colorectal cancer 
than that in poorly differentiated colorectal cancer (22.9% vs 
0%, p<0.01). In this case, the expression of KLF4 protein was 
significantly correlated with the differentiation in the colorectal 
cancer (p<0.01). Loss of expression of KLF4 or loss of its expres-
sion pattern may lead to more poorly differentiation. The KLF4 
expressions of specimens of stage I or II were also differed from 
the specimens that are diagnosis in the stage of III or IV (p<0.05).
3. Immunohistochemistry for KLF4 in colon and rectum
KLF4 expression was examined in TMAs collected from his-
tology sections of normal colon, adenomatous polyp, and colon 
cancer. The immunostain patterns differed in different types of 
specimens. Strongly KLF4 immunostains were predominantly 
cytoplasmic at normal crypt epithelium, and mainly distributed 
around the nucleus, which showed obvious cell polarity (Fig. 
1A). In colonic adenoma (Fig. 1B), cell polarity was also ob-
served, while the localization of the KLF4 immunostains were 
cytoplasmic and nuclear in the crypt epithelium. Downregula-
tion of KLF4 expression and loss of cell polarity were detected 
in the course of malignant transformation from normal to carci-
noma (Fig. 1F).
KLF4 expression also differed among different types of carci-
noma. Poorly differentiated carcinomas (Fig. 1E) were charac-
terized with lighter yellow staining in cytoplasm compared to 
well/moderately differentiated carcinoma (Fig. 1C and D). This 
was coincident with the positive percentage of the KLF4 stain-
ing (Table 2). And the localization of KLF4 immunostaining was 
mainly in cytoplasm, while yellow-stained nucleus also was 
detected in some part of the cells.  
4. Expression of KLF4 transcript in colon and rectum  
RT-PCR was performed on total mRNA isolated from fresh 
specimens of cancerous and noncancerous portions. The PCR 
product was designed to be 435 bp. The positive control was 
β-actin. The levels of KLF4 mRNA were lower in the colorectal 
mucosa than in normal colon (Fig. 2).
5. Expression of KLF4 protein in colon and rectum  
As showed in Fig. 3, the expression of KLF4 protein was low-
er in colorectal tumor than that in normal-appearing colorectal 
Fig. 3. Western bolt analysis of KLF4 protein expression in colorectal 
tissue. High KLF4 expression is detected in normal colorectal and 
well-differentiated tissues. Moreover, a downregulation of expression 
is observed in poorly differentiated colorectal cancer tissues. Lanes 1 
and 3 show KLF4 expression in normal-appearing tissues, while the 
other lanes show expression in cancerous specimens.
Fig. 2. RT-PCR analysis of KLF4 transcript expression in colonic 
tissues. KLF4 mRNA is highly expressed in normal tissue and down-
regulated in colorectal cancer tissue. Lane 1, molecular marker; Lanes 
2 and 4, β-actin and KLF4 PCR products in normal mucosa; Lanes 
3 and 5, β-actin and KLF4 PCR products in colorectal cancer speci-
mens.
Fig. 4. Western blot analysis of KLF4 expression in RKO cells. KLF4 
protein expression is elevated in RKO cells treated with butyrate in 
a dose-dependent manner. Lanes 1-4 show results from cells treated 
with 0, 1, 2, and 3 mM butyrate, respectively.158  Gut and Liver, Vol. 5, No. 2, June 2011
mucosa.
6. Expression of KLF4 protein in RKO cells 
As showed in Fig. 4, the expression of KLF4 protein was el-
evated in RKO treated with butyrate in a dose-dependent man-
ner.
DISCUSSION
Cancer cells differ from normal cells in many aspects, includ-
ing hyperproliferation and loss of differentiation. The recent 
concept of colonic carcinogenesis begins with damage to nor-
mal cellular genes, such as the activation of oncogenes, or the 
loss of the tumor suppressor genes. The loss of chromosome 9q, 
in which KLF4 resides, is observed in 25% to 50% of sporadic 
CRC.
12 Zhao et al.
13 found evidence for loss of heterozygosity 
(LOH) in two of eight surgically resected CRC specimens, and 
further studies in colorectal cancer cell lines also confirmed that 
in five of six exhibited LOH while other cell line RKO was found 
to be hemizygous deletion in the KLF4 gene. Krüppel like factor 
4, a eukaryotic transcription factor expressed extensively in the 
gastrointestinal tract, was turned out to be a potential tumor 
suppressor gene in the colorectal cancer. 
In this report, we analyzed the expression patterns of KLF4 
in Chinese sporadic colorectal cancers to study the relationship 
between KLF4 expression and clinicopathological parameters. 
Our studies showed that the negative and weak positive rate 
of normal appearing mucosa, adenoma, and carcinoma were 
42.5%, 71.4%, and 82.3%, and the expression level of KLF4 
in carcinoma, as compared to normal appearing mucosa, is 
statistically significant (p<0.05), which sames that the down-
regultaion of KLF4 is a precancer lesion in colon and rectum. 
Western blot and RT-PCR were also performed to confirm the 
results. This data was also supported by the result of northern 
blot analysis in precious studies.
6,13 All those results meant the 
downregulation of KLF4 expression in the course of malignant 
transformation, and indicated that KLF4 is closely correlated 
with differentiation and may be a potential tumor suppressor 
gene in colorectal cancer.
We also found that the expression patterns of KLF4 differed 
according to differentiation type of colorectal cancer. Higher 
percentage of strong positive expression of KLF4 was detected 
in well and moderately differentiated colorectal cancer than 
in the poorly differentiated ones. (22.9% vs 0%) (p<0.01). This 
result was different from Choi et al.
14 The distinct point here 
is that KLF4 expression patterns differed in different stage of 
the specimens (p<0.05). Strong KLF4 expression was found in 
26.5% of stage I or II, and it was down to 7.1% of stage III or 
IV. The reasons were not clear. It could be due to the different 
genetic background or the reasonable sampling error. It was co-
incident with recent study of Patel et al.
15 that they showed an 
obvious trend of a decreased odds ratio at higher stages com-
pared with stage I cancer. Those suggested that the loss of KLF4 
or its expression pattern leads to poor differentiation.
KLF4 expression was correlated with the differentiation in 
CRC in vivo, more and more studies were performed in vitro to 
support this. Sodium butyrate, a differentiation promoting agent 
of colon cancer,
16 could induce KLF4 mRNA expression and 
stimulated KLF4 promoter activity in a dose- and time-depen-
dent manner in HT-29 cells.
17 In our study, the protein levels of 
KLF4 were elevated in the colorectal cancer cell line RKO treated 
with 0 to 3 mM butyrate in a dose-dependent manner. RKO cells 
induced to overexpression of KLF4 demonstrated a correspond-
ing dose-dependent increase in intestinal alkaline phosphatase 
(IAP) expression, which is known as enterocyte differentiation 
marker.
18 This notion is further supported by the identification 
of that KLF4 plays an important role in colonic epithelial cell 
differentiation, and it is a goblet cell specific differentiation 
factor. KLF4
-/- mice displayed marked decrease in the number 
of goblet cells and abnormal goblet cell morphology.
19 Loss of 
KLF4 in mice also caused altered differentiation and precancer-
ous changes in the adult stomach.
20 This reminded the critical 
role of KLF4 in regulating the differentiation of colorectal can-
cer. Further studies are needed to analyze the role of KLF4 in 
the regulation of cell cycle in the colorectal cancer cell.
But it is still premature to say that the upregulation of KLF4 
is the cause of differentiation. In the recent study of stem cells, 
it is demonstrated that induction of pluripotent stem cells  from 
mouse embryonic or adult fibroblasts by introducing four fac-
tors which including KLF4.
21 KLF4 was also downregulated at 
early stage of mouse embryonic stem cells differentiation.
22 
These studies showed the dual role of KLF4 in cell differentia-
tion. The expression patterns differed in different cells. 
We did not found the level of KLF4 had correlation with the 
sex, age, pathology type, and metastasis state (p>0.05), which 
was consistent with findings from Choi et al.
14
In conclusion, our results showed the downregulation of KLF4 
expression in the course of progressive malignant transforma-
tion, and indicated that KLF4 was significantly correlated with 
differentiation and may be a potential tumor suppressor gene in 
colorectal cancer. 
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